ZBIO - CIK 0001953926
Zenas BioPharma, Inc. (ZBIO) reported revenue of $10.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $10.00M | +100.0% |
| FY 2024 | $5.00M | -90.0% |
| FY 2023 | $50.00M | - |
Zenas BioPharma, Inc. (ZBIO) reported revenue of $10.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.